نتایج جستجو برای: invasive candidiasis

تعداد نتایج: 151827  

Journal: :Therapeutics and Clinical Risk Management 2008
Kathryn Sabol Tawanda Gumbo

More antifungal agents have reached clinical use in the past two decades than at any other time. The echinocandins have been a welcome addition to this group, with the latest being anidulafungin. There are several lines of evidence to support anidulafungin's role as primary therapy for the treatment of invasive candidiasis in non-neutropenic patients, and as alternative therapy to fluconazole i...

2013
Michail S. Lionakis Mihai G. Netea

Candida is the most common human fungal pathogen and the cause of invasive candidiasis, the fourth leading cause of nosocomial bloodstream infection in the United States with an estimated annual cost of ,US$2 billion and mortality that exceeds 40% despite administration of antifungal therapy in modern intensive care unit facilities [1]. Hence, invasive candidiasis is an unmet medical condition ...

Journal: Current Medical Mycology 2018
Behnam Honarvar, Esmaeil Mortaz, Ghasem Vahedi, Kamran Bagheri Lankarani, mehdi taghavi,

Invasive fungal infections (IFIs) are among the life-threatening issues in patients with impaired immune system. High administration of antifungals in these patients imposes a heavy economic burden on the national health system. In addition, despite the usually expensive antifungal regimens, the mortality rate due to fungal infections is still high, resulting in the loss of hundreds of lives pe...

Journal: :Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2012
M Cuenca-Estrella P E Verweij M C Arendrup S Arikan-Akdagli J Bille J P Donnelly H E Jensen C Lass-Flörl M D Richardson M Akova M Bassetti T Calandra E Castagnola O A Cornely J Garbino A H Groll R Herbrecht W W Hope B J Kullberg O Lortholary W Meersseman G Petrikkos E Roilides C Viscoli A J Ullmann

As the mortality associated with invasive Candida infections remains high, it is important to make optimal use of available diagnostic tools to initiate antifungal therapy as early as possible and to select the most appropriate antifungal drug. A panel of experts of the European Fungal Infection Study Group (EFISG) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID...

Journal: :Journal of clinical pathology 2004
C Monteagudo A Viudes A Lazzell J P Martinez J L Lopez-Ribot

BACKGROUND The morphogenetic conversion between yeast and hyphal growth forms appears to be crucial in the pathogenesis of invasive candidiasis, and can be regulated by environmental signals such as extracellular pH. AIMS To characterise the epitope recognised by monoclonal antibody 1H4, and to evaluate the expression of its corresponding epitope in Candida albicans cells under different cond...

ژورنال: پوست و زیبایی 2022
fattahi, mahsa, Lotfali, Ensieh ,

Background and Aim: Oral candidiasis is a common opportunistic disease of oral cavity particularly in neonates because of Candida overgrowth. Colonization of infant’s oral mucosa with Candida species is the primary stage for invasive candidiasis. The aim of the present study was to determine the association of risk factors and oral candidiasis. Methods: specimens were obtained from 70 infants ...

Journal: :Acta paediatrica 2009
Luca Filippi Chiara Poggi Elena Gozzini Rosanna Meleleo Lorenzo Mirabile Patrizio Fiorini

UNLABELLED Candidiasis is relatively frequent in neonatal and pediatric intensive care units (ICUs), particularly in preterm infants less than 28 weeks of gestational age. Neonatal candidiasis shows high mortality and is often associated to poor neurodevelopmental prognosis in survivor patients. Amphotericin B and fluconazole are the first choice drugs for the treatment of neonatal candidiasis....

2013
José Endrigo Tinoco-Araujo Diana Ferreira Gadelha Araújo Patrícia Gomes Barbosa Paulo Sérgio da Silva Santos Ana Myriam Costa de Medeiros

OBJECTIVE To investigate prevalence of invasive candidiasis in a Neonatal Intensive Care Unit and to evaluate oral diseases and Candida spp. colonization in low birth weight preterm newborns. METHODS A descriptive epidemiological study performed in two stages. First, prevalence of candidiasis was analyzed in a database of 295 preterm patients admitted to hospital for over 10 days and birth we...

Journal: :Archives of disease in childhood. Fetal and neonatal edition 2001
F Adler-Shohet H Waskin J M Lieberman

This study describes the safety and efficacy of amphotericin B lipid complex (ABLC) in 11 neonates with systemic Candida infections. Nine of the 11 improved clinically, and eight of nine evaluable patients had a mycological cure with ABLC. Creatinine levels improved or did not significantly change in eight of the 11 patients.

2015
Xiao-juan Wang Xue Sui Lan Yan Yan Wang Yong-bing Cao Yuan-ying Jiang

Candida albicans is the most common cause of hematogenously disseminated candidiasis, and this disease is particularly prevalent in immunocompromised patients. The mortality of invasive candidiasis remains 40% to 50% even with the proper treatment with current antifungal drugs. Recently, with the better understanding of host-fungus interactions, notable progress has been made in antifungal vacc...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید